Page last updated: 2024-08-24

ibandronic acid and Hip Fractures

ibandronic acid has been researched along with Hip Fractures in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Dong, S; Hu, Y; Ke, Z; Lv, M; Shen, J; Song, L; Wu, K; Xu, K; Yuan, Y1
Bonel, H; Everts-Graber, J; Gahl, B; Häuselmann, H; Lehmann, D; Lehmann, T; Reichenbach, S; Studer, U; Ziswiler, HR1
Ciornohac, JF; Mathonet, PY; Willems, S1
Reid, IR1
Barr, CE; Blumentals, WA; Harley, C; Harris, ST; Poston, SA; Reginster, JY; Silverman, SL1
Abelson, A; Gold, DT; Lange, JL; Ringe, JD; Thomas, T1
Nonaka, K; Uchiyama, S1
Chesnut, CH; Gass, ML; Hamdy, RC; Holick, MF; Leib, ES; Lewiecki, ME; Maricic, M; Watts, NB1

Reviews

3 review(s) available for ibandronic acid and Hip Fractures

ArticleYear
Pharmacological Therapies for Osteoporosis: A Bayesian Network Meta-Analysis.
    Medical science monitor : international medical journal of experimental and clinical research, 2022, Apr-17, Volume: 28

    Topics: Bone Density; Bone Density Conservation Agents; Female; Hip Fractures; Humans; Ibandronic Acid; Network Meta-Analysis; Osteoporosis; Osteoporosis, Postmenopausal; Risedronic Acid; Spinal Fractures

2022
[Assessment of volumetric bone mineral density and geometry for hip with clinical CT device].
    Clinical calcium, 2011, Volume: 21, Issue:7

    Topics: Aged; Aged, 80 and over; Bone Density; Densitometry; Diphosphonates; Female; Femur; Hip Fractures; Humans; Ibandronic Acid; Life Style; Middle Aged; Risk; Teriparatide; Tomography, X-Ray Computed

2011
Review of treatment modalities for postmenopausal osteoporosis.
    Southern medical journal, 2005, Volume: 98, Issue:10

    Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Calcium; Combined Modality Therapy; Diet; Dietary Supplements; Diphosphonates; Etidronic Acid; Exercise; Female; Fish Oils; Hip Fractures; Humans; Ibandronic Acid; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risedronic Acid; Teriparatide; Vitamin D; Vitamin D Deficiency

2005

Other Studies

5 other study(ies) available for ibandronic acid and Hip Fractures

ArticleYear
Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2023, Volume: 34, Issue:11

    Topics: Aged; Alendronate; Bone Density Conservation Agents; Cohort Studies; Denosumab; Diphosphonates; Female; Hip Fractures; Humans; Ibandronic Acid; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Registries; Spinal Fractures; Zoledronic Acid

2023
[Subtrochanteric pathological fracture on bisphosphonates].
    Revue medicale de Liege, 2018, Volume: 73, Issue:2

    Topics: Aged; Alendronate; Bone Density Conservation Agents; Diphosphonates; Female; Fractures, Spontaneous; Hip Fractures; Humans; Ibandronic Acid

2018
Efficacy, effectiveness and side effects of medications used to prevent fractures.
    Journal of internal medicine, 2015, Volume: 277, Issue:6

    Topics: Alendronate; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium Compounds; Denosumab; Diphosphonates; Etidronic Acid; Evidence-Based Medicine; Hip Fractures; Humans; Ibandronic Acid; Imidazoles; Osteoporosis; Osteoporotic Fractures; Raloxifene Hydrochloride; Risedronic Acid; Risk Assessment; Spinal Fractures; Teriparatide; Thiophenes; Treatment Outcome; Vitamin D; Zoledronic Acid

2015
Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: the eValuation of IBandronate Efficacy (VIBE) database fracture study.
    Bone, 2009, Volume: 44, Issue:5

    Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Cohort Studies; Diphosphonates; Drug Administration Schedule; Female; Fractures, Bone; Hip Fractures; Humans; Ibandronic Acid; Middle Aged; Osteoporosis; Retrospective Studies

2009
Longitudinal change in clinical fracture incidence after initiation of bisphosphonates.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:6

    Topics: Age Factors; Aged; Alendronate; Bone Density Conservation Agents; Diphosphonates; Epidemiologic Methods; Etidronic Acid; Female; Hip Fractures; Humans; Ibandronic Acid; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Risedronic Acid; United States

2010